VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Jun 2, 2020
Document Date
May 29, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
Watkins Thomas
Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |